1. Home
  2. IMRX vs NCSM Comparison

IMRX vs NCSM Comparison

Compare IMRX & NCSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMRX
  • NCSM
  • Stock Information
  • Founded
  • IMRX 2008
  • NCSM 2006
  • Country
  • IMRX United States
  • NCSM United States
  • Employees
  • IMRX N/A
  • NCSM N/A
  • Industry
  • IMRX Biotechnology: Pharmaceutical Preparations
  • NCSM Oilfield Services/Equipment
  • Sector
  • IMRX Health Care
  • NCSM Energy
  • Exchange
  • IMRX Nasdaq
  • NCSM Nasdaq
  • Market Cap
  • IMRX 62.7M
  • NCSM 68.4M
  • IPO Year
  • IMRX 2021
  • NCSM 2017
  • Fundamental
  • Price
  • IMRX $2.02
  • NCSM $29.45
  • Analyst Decision
  • IMRX Buy
  • NCSM
  • Analyst Count
  • IMRX 7
  • NCSM 0
  • Target Price
  • IMRX $12.80
  • NCSM N/A
  • AVG Volume (30 Days)
  • IMRX 4.9M
  • NCSM 10.4K
  • Earning Date
  • IMRX 02-28-2025
  • NCSM 03-06-2025
  • Dividend Yield
  • IMRX N/A
  • NCSM N/A
  • EPS Growth
  • IMRX N/A
  • NCSM N/A
  • EPS
  • IMRX N/A
  • NCSM 16.77
  • Revenue
  • IMRX N/A
  • NCSM $152,801,000.00
  • Revenue This Year
  • IMRX N/A
  • NCSM $13.26
  • Revenue Next Year
  • IMRX N/A
  • NCSM $6.32
  • P/E Ratio
  • IMRX N/A
  • NCSM $1.76
  • Revenue Growth
  • IMRX N/A
  • NCSM 3.66
  • 52 Week Low
  • IMRX $1.00
  • NCSM $14.73
  • 52 Week High
  • IMRX $7.68
  • NCSM $30.44
  • Technical
  • Relative Strength Index (RSI)
  • IMRX 47.82
  • NCSM 63.99
  • Support Level
  • IMRX $1.84
  • NCSM $27.10
  • Resistance Level
  • IMRX $3.80
  • NCSM $29.67
  • Average True Range (ATR)
  • IMRX 0.29
  • NCSM 1.25
  • MACD
  • IMRX -0.03
  • NCSM 0.09
  • Stochastic Oscillator
  • IMRX 9.18
  • NCSM 84.01

About IMRX Immuneering Corporation

Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.

About NCSM NCS Multistage Holdings Inc.

NCS Multistage Holdings Inc provides products and support services that facilitate the optimization of oil and natural gas well completions and field development strategies. NCS provides its products and services to exploration and production companies for use in onshore wells, predominantly wells that have been drilled with horizontal laterals in unconventional oil and natural gas formations. The company's primary offering is its fracturing systems products and services, which enable efficient pinpoint stimulation: the process of individually stimulating each entry point into a formation targeted by an oil or natural gas well. Geographically, majority of revenue is generated from United States.

Share on Social Networks: